|
|
|
1-10 employees
View all
|
|
Pharmaceuticals
|
|
213 Technology Drive,Irvine,CA,United States
|
|
CoCensys was founded in 1989 with a successful IPO in 1993, it acquired ACEA Pharmaceuticals in 1994, divested its Sales and Marketing Division to Watson Pharmaceuticals in 1997, and was acquired by Purdue Pharma in 1999.CoCensys developed allosteric modulators of the GABA-A receptor, modulators of NMDA and AMPA receptors, and sodium channel blockers with equipotent inhibitory actions at NaV1.8 and NaV1.6 isoforms. It had co-development and licensing agreements with Novartis, Parke-Davis, Searle, and Wyeth-Ayerst. The neuroactive steroid ganaxolone, a positive allosteric modulator of GABA-A receptors, is currently in Phase 3 development by Marinus Pharmaceuticals.
|
CoCensys Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used CoCensys email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact CoCensys customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.